ArticleJournal of human hypertension2017
Hyperkalemia in both surgically and medically treated patients with primary aldosteronism.
Article in Journal of human hypertension, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 22 citations in OpenAlex.
- Treatment for patients with unilateral aldosteronism: surgical or medical treatment.Hypertension research : official journal of the Japanese Society of Hypertension · 2025Article
- Severe hydronephrosis complicated with primary aldosteronism: a case report and review of the literature.Journal of medical case reports · 2024Review
- Practical consensus for the treatment and follow-up of primary aldosteronism: a multidisciplinary consensus document.Endocrine · 2024Review
- Biomarkers to Guide Medical Therapy in Primary Aldosteronism.Endocrine reviews · 2024Review
- 2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary Aldosteronism.Endocrinology and metabolism (Seoul, Korea) · 2023Article
- Usefulness of Alternative Therapy with Hydrocortisone in the Postoperative Management of Severe Primary Aldosteronism.Internal medicine (Tokyo, Japan) · 2023Article
- [Persistent and serious hyperkalemia after surgery of primary aldosteronism: A case report].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2022Review
- Primary aldosteronism in elderly, old, and very old patients.Journal of human hypertension · 2020Review
- Severe Persistent Hyperkalemia with Electrocardiogram Changes in a Patient with Hyperaldosteronism.Cureus · 2020Article
- The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism.International Journal of Cardiology. Hypertension · 2020Review
- Persistent severe hyperkalemia following surgical treatment of aldosterone-producing adenoma.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 8 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyperkalemia is an important complication of adrenalectomy for patients with primary aldosteronism (PA). The frequency of hyperkalemia after medication using mineralocorticoid receptor antagonists (MRAs) for PA is unclear. The aim of this study is to investigate the frequency and the risk factors of hyperkalemia after surgery and medication for PA. The data of 376 patients with PA registered in a multicentre-collaborative study in Japan, including surgically treated patients (group A; n=142) and medically treated patients with MRAs (group B; n=234) were studied. The prevalence of hyperkalemic patients (serum potassium >5.0 mEq l
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.